nci logo
NIH
U.S. National Institutes of Health National Cancer Institute

SEER Inquiry System - View

Print Question
Question: 20120078
Status
Final

References
Source 1:   2007 MP/H Rules
pgs:  
Notes:   Terms & Defs
Source 2:   2012 SEER Manual
pgs:   77
Notes:  


Question
Reportability--Melanoma: Upon review of SINQ 20020019 and 20041034 the terms "early" or "evolving" melanoma are not reportable. Does the addition of a "Clarks Level I " change reportability? See discussion.

Discussion
7/21: c/w evolving lentigo maligna

7/29: path review of bx specimen: Comment: “pattern c/w lentigo maligna”. Diagnosis: c/w evolving lentigo maligna.

10/20:Re-Exc: Recent bx site & atypical lentiginous melanocytic proliferation c/w persistent early malignant melanoma in situ, lentiginous type, Clark’s level I, margins free. The results of the previous outside pathology report were reviewed.

I know that “early” and “evolving” melanoma are not reportable, but when they give a Clark’s level, does the case then become reportable?

Answer
Mention of Clark Level 1 can be interpreted as in situ, making this case reportable.

Early and evolving melanoma are not reportable. However, Clark level 1 is listed as synonymous with in situ on page 77 of the 2012 SEER manual.

History


Last Updated
12/18/2012

Date Finalized
12/18/2012